Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer

Cancer Immunology Immunotherapy

Volumn 49, Issue 7, 2000, Pages 388-394

  Pellegrini, Patrizia ^a   Contasta, Ida ^a   Berghella, Anna Maria ^a   Gargano, Estevano ^b   Mammarella, Cesare ^c   Adorno, Domenico ^a  

^a CNR   (Italy)

^b Ospedale di Cento Fe   (Italy)

^c SS Annunziata Hospital   (Italy)

Author keywords

Colorectal cancer; Prognostic and diagnostic indices; sCEA; TIMP1

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; COLLAGENASE; MATRIX METALLOPROTEINASE; PROTEIN ANTIBODY; PROTEIN P53; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BLOOD LEVEL; CANCER INFILTRATION; CANCER INVASION; CANCER STAGING; COLORECTAL CANCER; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MULTIGENE FAMILY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033858976     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620000129     Document Type: Article

References (30)

1. Humoral immune response against p53 protein in patients with colorectal carcinoma
2. Immunohistochemical study of MT-MMP tissue status in gastric carcinoma and correlation with survival analyzed by univariate and multivariate analysis
3. Carcinoembryonic antigen, a human tumor marker, functions as intercellular adhesion molecule
4. Progression mechanisms in colon cancer: Soluble interleukin-2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and tumour stage correlations
5. IL-10 and sIL2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer
6. Clinico-pathological characteristics of colorectal cancer and serum anti-p53 antibodies
7. Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain
8. Purification of rabbit bone inhibitor of collagenase
9. The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor
10. The role of the soluble CD30 serum level in colorectal cancer: A possible marker for a patient subset which could benefit from IL-2 biotherapy
11. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma
12. Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension
13. Antibodies against p53 are associated with poor prognosis of colorectal cancer
14. Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas
15. Cancer. p53, Guardian of the genome
16. Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: Distribution on primary structure and exposure on protein surface
17. Prognostic value of p53 protein expression for patients with gastric cancer - A multivariate analysis
18. High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer
19. Mathematical modeling of immunologica reactions
20. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes
21. Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields fully active inhibitor
22. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma correlation with tumor progression and survival
23. Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours
24. Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer
25. Susceptibility of colorectal-carcinoma cells to natural killer mediated lysis: Relationships to CEA expression and degree of differentiation
26. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis
27. Cell kinetics, p53 and bcl-2 expression, and c-Ki-ras mutations in flat-elevated tubulovillous adenomas and adenocarcinomas of the colorectum: Comparison with polypoid lesions
28. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family
29. The immunoglobulin superfamily-domains for cell-surface recognition
30. Specificity of intercellular adhesion mediated by various members of the immunoglobulin supergene family